World's 1st reverse aging vegan skincare
A new era of natural skincare fully backed by science. Invented by the pioneers of one the world's most successful cosmeceuticals.
Over 75 years of experience in reverse aging skincare
Good things take time. The story of nor sken begins some 30 years ago, when Swedes Lars Brittsjo and Lars Kärnerud launched the world’s first beauty supplement: Imedeen and changed the way the world approached skincare. Working on a cellular level, Imedeen’s age-defying elixir d introduced millions around the world to the concept of cosmeceuticals.
The duo’s latest innovation, nor sken anti-ageing skincare, draws on the powers of science and nature to supercharge the production of crucial proteins that create younger-looking, healthy skin. A single-step regime, the cream stays true to Scandinavian simplicity, while changing the way we age in a remarkable way.
50% more powerful than retinol, yet gentle.
Our Founders
Lars Brittsjo
Founder
Lars Britsjo has dedicated his career to sustainably improving the human condition, developing and launching revolutionary healthcare products. He began his career in optometry, evolving into a key player behind Imedeen’s global success. Lars went on to launch health food and nutraceuticals brand Xndo, before returning to his passion for anti-ageing skincare solutions.
Lars Kärnerud
Co-Founder
Lars Kärnerud is an industry veteran, whose interest in unique ingredients and research led to the success of innovative products under his wing, such as Imedeen. A global authority on anti-ageing cosmeceuticals, he continues to contribute his wisdom io industry bodies in Sweden, alongside his latest collaboration with Lars Brittsjo, nor sken.
Jan Faergemann
Professor (Dermatology), Gothenburg University, Sweden Scientific Advisor
A world-leading specialist in dermatology, and now Scientific Advisor to nor sken, Prof Faergemann has authored more than 230 scientific papers in respected international medical journals. His expertise lies in clinical trials, having performed more than 50 clinical trials throughout his career, and supervised and taught numerous courses in Good Clinical Practice – the “gold standard” in the field.